BDBM223017 US10034939, Example 19::US10967060, Example 19::US11207302, Example 19::US9320732, 19::US9789094, 19

SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO

InChI Key InChIKey=GHLDPOHYOPWBDC-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 223017   

TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM223017(US10034939, Example 19 | US10967060, Example 19 | ...)
Affinity DataIC50: <500nMpH: 6.5 T: 2°CAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM223017(US10034939, Example 19 | US10967060, Example 19 | ...)
Affinity DataIC50: <500nMpH: 6.5 T: 2°CAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM223017(US10034939, Example 19 | US10967060, Example 19 | ...)
Affinity DataIC50: <500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM223017(US10034939, Example 19 | US10967060, Example 19 | ...)
Affinity DataIC50: <500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM223017(US10034939, Example 19 | US10967060, Example 19 | ...)
Affinity DataIC50: <500nMAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Incyte

US Patent
LigandPNGBDBM223017(US10034939, Example 19 | US10967060, Example 19 | ...)
Affinity DataIC50: <500nMpH: 6.5 T: 2°CAssay Description:Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent